Skip to main content

Advertisement

Table 5 Random effects regression-dependent variable is bid on ST product (N = 258)

From: The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions

Characteristics   Model 1 Model 2 Model 3
Product bid upon Intercept 0.97 −1.60 −1.20
(0.71)+ (0.72) (0.72)
Nicorette 0.89*** 0.89*** 0.89***
(0.13) (0.13) (0.13)
Ariva 0.35*** 0.35*** 0.37***
(0.13) (0.13) (0.13)
In treatment where offered, but rejected opportunity to take a trial, relative to control group Offered but rejected Snus −0.54 −0.06 −0.13
(0.39) (0.35) (0.35)
Offered but rejected Nicorette 0.95** 0.87** 0.50
(0.46) (0.41) (0.40)
Offered but rejected Ariva −0.08 0.05 0.01
(0.46) (0.41) (0.40)
In treatment where offered, and accepted opportunity to take a trial, relative to control group Tried Snus −0.07 0.11 0.08
(0.42) (0.38) (0.37)
Tried Nicorette 0.20 0.27 0.23
(0.38) (0.34) (0.33)
Tried Ariva 0.18 −0.04 −0.06
(0.38) (0.34) (0.33)
Age −0.00 0.01 0.00  
(0.01) (0.01) (0.01)  
Income −0.09 −0.08 −0.06  
(0.10) (0.09) (0.09)  
Education 0.12 −0.08 0.15  
(0.11) (0.09) (0.10)  
Female 0.15 0.14 0.11  
(0.28) (0.25) (0.24)  
Race/Ethnicity Black vs. white 0.16 0.03 −0.01
(0.32) (0.28) (0.29)
Other vs. white 0.57 0.05 0.13
(0.48) (0.43) (0.42)
State South Carolina (vs. New York) −0.82 0.09 0.03
(0.31) (0.29) (0.30)
Pennsylvania (vs. New York) −1.04*** −0.87*** −0.84***
(0.32) (0.29) (0.28)
Ever used smokeless tobacco 0.10 0.09 0.04
(0.29) (0.26) (0.25)
Worried about their quality of life because of smoking −0.01 0.06 −0.01
(0.24) (0.22) (0.21)
Estimate of the cost of smokeless tobacco products 0.02** 0.02*** 0.02***
(0.01) (0.01) (0.01)
Bid for cigarettes   0.40*** 0.38***
  (0.05) (0.05)
Participant preferred menthol cigarettes    −0.06
  (0.23)
  1. **Statistically significant at the 0.05 level
  2. ***Statistically significant at the 0.01 level
  3. +Robust standard errors are reported in parentheses